Development of Machine Learning Platforms that Accelerate Drug Discovery and Molecular Screening for Cancers, Autoimmune Diseases, And Neurological Disorders. AJEMA [Internet]. 2025 Dec. 4 [cited 2026 Jan. 27];3(12):8-18. Available from: https://grnjournal.us.e-scholar.org/index.php/AJEMA/article/view/8731